Skip to content
healthcare.dev

APRISO

NDC 65649-103, mesalamine, capsule, extended release, from Salix Pharmaceuticals, Inc..

Product NDC
65649-103
Status
Listed
Labeler
Salix Pharmaceuticals, Inc.
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022301
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65649-103 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MESALAMINE375 mg/1

Pharmacologic classes

Aminosalicylate [EPC]; Aminosalicylic Acids [CS]

Package NDCNDC-11Package
65649-103-01656490103011 BOTTLE in 1 CARTON (65649-103-01) / 4 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
65649-103-02656490103021 BOTTLE in 1 CARTON (65649-103-02) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7951139c-b271-45a4-b523-34b23800917b

Use it

Look up 65649-103 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65649-103 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65649-103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.